Related Experiment Videos
Glucocorticoid therapy and diabetes management
1Section of Endocrinology and Metabolism, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA. jvolgi@rush.edu
The Nursing Clinics of North America
|May 31, 2001
Summary
Glucocorticoid therapy can worsen existing diabetes or cause new steroid-induced diabetes. This article explains these effects and provides case studies for optimal diabetes management during glucocorticoid treatment.
Area of Science:
- Endocrinology
- Metabolic Disorders
Background:
- Glucocorticoids are widely used anti-inflammatory and immunosuppressive agents.
- Their metabolic side effects, particularly on glucose homeostasis, are significant.
- Understanding these effects is crucial for patient care.
Observation:
- Glucocorticoid administration can lead to hyperglycemia.
- Pre-existing diabetes mellitus may experience significant worsening.
- New-onset diabetes, termed steroid-induced diabetes, can be precipitated.
Findings:
- Glucocorticoids impair insulin secretion and increase insulin resistance.
- They promote hepatic gluconeogenesis and muscle glucose uptake.
- The degree of glycemic dysregulation varies based on dose, duration, and individual susceptibility.
Implications:
- Close monitoring of glucose levels is essential for patients on glucocorticoid therapy.
- Antidiabetic medication regimens may require adjustment.
- Proactive management strategies are necessary to prevent or mitigate hyperglycemia and its complications.